Peginesatide (Omontys): Recalled due to serious hypersensitivity

FDA alerts health care providers of recall of anemia drug Omontys (02/24/2013) Omontys Injection by Affymax and Takeda: Recall of All Lots – Serious Hypersensitivity Reactions (02/23/2013)